1. Volume 84, Issue 5, Pages 1047-1048 (November 2013)
The Authors Reply 
Shokei Kim-Mitsuyama, Hisao Ogawa, Kunihiko Matsui, Tomio Jinnouchi, Hideaki Jinnouchi, Kikuo Arakawa 
Kidney International 
Volume 84, Issue 5, Pages (November 2013)
DOI: /ki
Copyright © 2013 International Society of Nephrology Terms and Conditions

2. Figure 1
Kaplan–Meier curves. For primary composite end points during the follow-up period in patients (a) with and (b) without proteinuria. ARB, angiotensin II receptor blocker; CCB, calcium channel blocker; CI, confidence interval; HR, hazard ratio.
Kidney International  , DOI: ( /ki )
Copyright © 2013 International Society of Nephrology Terms and Conditions